New Biotech Viscient Partners with Organovo on Fatty Liver Disease
Xconomy
NOVEMBER 6, 2017
The San Diego company, founded a decade ago on 3D bio-printing technology developed by the University of Missouri’s Gabor Forgacs, appeared to be gaining momentum on multiple fronts. In a related initiative, Organovo began moving to develop larger “patches” of 3D-printed human liver tissue for potential use in transplantation in.
Let's personalize your content